Sự suy giảm lâm sàng gia tăng ở bệnh nhân có trình độ học vấn cao với sự thoái hóa thùy trán-thùy thái dương

Anneser JM, Jox RJ, Borasio GD (2007) Inappropriate sexual behaviour in a case of ALS and FTD: successful treatment with sertraline. Amyotroph Lateral Scler 8:189–190 Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL (2003) Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60:1909–1915 Borroni B, Grassi M, Agosti C, Premi E, Archetti S, Alberici A, Bellelli G, Caimi L, Di Luca M, Padovani A (2008) Establishing short-term prognosis in frontotemporal lobar degeneration spectrum: role of genetic background and clinical phenotype. Neurobiol Aging Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM (2003) Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60:1005–1011 Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314 Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ (2004) Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl) 172:400–408 Diehl-Schmid J, Forstl H, Perneczky R, Pohl C, Kurz A (2008) A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry 23:754–759 Diehl-Schmid J, Pohl C, Perneczky R, Forstl H, Kurz A (2006) Behavioral disturbances in the course of frontotemporal dementia. Dement Geriatr Cogn Disord 22:352–357 Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626 Fellgiebel A, Muller MJ, Hiemke C, Bartenstein P, Schreckenberger M (2007) Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. World J Biol Psychiatry 8:123–126 Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198 Graff-Radford NR, Ferman TJ, Lucas JA, Johnson HK, Parfitt FC, Heckman MG, Todd M, Sadowsky C, Epstein DE, Crook JE (2006) A cost effective method of identifying and recruiting persons over 80 free of dementia or mild cognitive impairment. Alzheimer Dis Assoc Disord 20:101–104 Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC (1999) Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 56:713–718 Harvey RJ, Skelton-Robinson M, Rossor MN (2003) The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 74:1206–1209 Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H (1998) The Bayer activities of daily living scale. Dement Geriatr Cogn Disord 9:20–26 Kertesz A, Davidson W, Fox H (1997) Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 24:29–36 Kertesz A, Morlog D, Light M, Blair M, Davidson W, Jesso S, Brashear R (2008) Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord 25:178–185 Kipps CM, Nestor PJ, Dawson CE, Mitchell J, Hodges JR (2008) Measuring progression in frontotemporal dementia: implications for therapeutic interventions. Neurology 70:2046–2052 Klempin F, Kempermann G (2007) Adult hippocampal neurogenesis and aging. Eur Arch Psychiatry Clin Neurosci 257:271–280 Kuhn HG, Cooper-Kuhn CM, Boekhoorn K, Lucassen PJ (2007) Changes in neurogenesis in dementia and Alzheimer mouse models: are they functionally relevant? Eur Arch Psychiatry Clin Neurosci 257:281–289 Lebert F, Pasquier F (1999) Trazodone in the treatment of behaviour in frontotemporal dementia. Hum Psychopharmacol Clin Exp 14:279–281 Lebert F, Stekke W, Hasenbroekx C, Pasquier F (2004) Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord 17:355–359 Mendez MF, Shapira JS, McMurtray A, Licht E (2007) Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 15:84–87 Moretti R, Torre P, Antonello RM, Cazzato G, Bava A (2003) Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol 49:13–19 Moretti R, Torre P, Antonello RM, Cazzato G, Bava A (2003) Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen 18:265–272 Moretti R, Torre P, Antonello RM, Cazzato G, Griggio S, Bava A (2003) Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer’s disease and other dementias: a 24-month follow-up of 68 patients. Am J Alzheimers Dis Other Demen 18:205–214 Mortimer JA, Snowdon DA, Markesbery WR (2003) Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol 25:671–679 Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554 Ngandu T, von Strauss E, Helkala EL, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2007) Education and dementia: what lies behind the association? Neurology 69:1442–1450 Perneczky R, Diehl-Schmid J, Drzezga A, Kurz A (2007) Brain reserve capacity in frontotemporal dementia: a voxel-based 18F-FDG PET study. Eur J Nucl Med Mol Imaging 34:1082–1087 Perneczky R, Diehl-Schmid J, Pohl C, Drzezga A, Kurz A (2007) Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve. Brain Res 1133:178–185 Perneczky R, Drzezga A, Diehl-Schmid J, Schmid G, Wohlschlager A, Kars S, Grimmer T, Wagenpfeil S, Monsch A, Kurz A (2006) Schooling mediates brain reserve in Alzheimer’s disease: findings of fluoro-deoxy-glucose-positron emission tomography. J Neurol Neurosurg Psychiatry 77:1060–1063 Perneczky R, Hartmann J, Grimmer T, Drzezga A, Kurz A (2007) Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment. J Geriatr Psychiatry Neurol 20:84–88 Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A (2006) Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry 14:139–144 Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58:1615–1621 Reitan R (1985) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276 Rosen HJ, Narvaez JM, Hallam B, Kramer JH, Wyss-Coray C, Gearhart R, Johnson JK, Miller BL (2004) Neuropsychological and functional measures of severity in Alzheimer disease, frontotemporal dementia, and semantic dementia. Alzheimer Dis Assoc Disord 18:202–207 Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448–460 Stern Y, Albert S, Tang MX, Tsai WY (1999) Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology 53:1942–1947 Swanberg MM (2007) Memantine for behavioral disturbances in frontotemporal dementia: a case series. Alzheimer Dis Assoc Disord 21:164–166 Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB (1995) Cognitive decline in Alzheimer’s disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol A Biol Sci Med Sci 50A:M49–M55 Thalmann B, Monsch A (1997) CERAD. The Consortium to Establish a Registry for Alzheimer’s Disease. Neuropsychologische Testbatterie. Memory Clinic Basel, Basel Valenzuela MJ, Sachdev P (2006) Brain reserve and cognitive decline: a non-parametric systematic review. Psychol Med 36:1–9